US-based BSD Medical has announced the start of a clinical trial by the University of Utah School of Medicine using BSD’s MicroThermX microwave ablation system for treating liver tumours.

Twenty patients will be enrolled in the prospective, non-randomised, single arm trial, which both cirrhotic and non-cirrhotic liver tissue will be evaluated in.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The trial’s main aim is to clinically assess the size of the ablation zones produced in liver tissue by BSD’s patented Synchronous Wave Alignment technology developed for MicroThermX.

"This trial will allow us to study the effects of the Synchronous Wave Alignment technology in both cirrhotic and non-cirrhotic liver tissue, and to determine if there is a difference in how the energy is absorbed in the two types of tissue."

University of Utah School of Medicine assistant professor of radiology Ryan O’Hara is the trial’s principal investigator.

"This trial will allow us to study the effects of the Synchronous Wave Alignment technology in both cirrhotic and non-cirrhotic liver tissue, and to determine if there is a difference in how the energy is absorbed in the two types of tissue," O’Hara said.

See Also:

BSD’s MicroThermX uses the Synchronous Wave Alignment technology to provide larger and more uniform zones of ablation across all tissue types during a single procedure.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The University of Utah trial will assess the ability of MicroThermX to create larger heating zones, using multiple antennas, than achieved by other available microwave ablation systems.

Simultaneously using multiple antennas gives physicians the ability to create a large, contiguous zone of necrosis with large margins.

The company said that larger, hotter heating zones may also decrease the occurrence of inadequate treatment of larger tumours.

MicroThermX is a compact, mobile, proprietary system that includes a microwave generator, single-patient-use disposable antennas and a thermistor-based temperature monitoring system.